20 ．Pathogen Genomics Center

variable-number

tandemrepeats

andthecomprehensive single nucleotide polymorphism. J1)

OdeH,Yokoyama

M,KandaT,andSato

Vet Med Sci. 72: 93-97. 2010.

H.

Identification of folding preferences of cleavage

8) Sato, H., Kusumoto-Matsuo, R., Ishii, Y., Mori, S.,

forNakahara, T., Shinkai-Ouchi, F., Kawana, K., Fujii,

regulation of cleavability. J. Mol. Model. In press

T., Taketani, Y., Kanda, T. and Kukimoto, I.

(2010)

Identification of nucleolin as a protein thatjunctionsofHIV-1precursor

proteinsbinds to human papillomavirus type 16 DNA. Biochem2) Onyango CO, Leligdowicz A, Yokoyama M, Sato H, SongBiophys Res Commun, 387, 525-530, 2009.

H, Nakayama EE, Shioda T, de Silva T, Townend J,
Jaye A, Whittle H, Rowland-Jones S, Cotten M. HIV-2
capsids distinguish high and low virus load9) Kondo, K, Ishii, Y, Mori, S, Shimabukuro, S,

patients in a West African community cohort.

Yoshikawa, H, Kanda, T. Nuclear location of minor

Vaccine. 28 Suppl 2:B60-7,2010.

capsid protein L2 is required for expression of areporter plasmid packaged in HPV51 pseudovirions.

3) Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H,Virology, 394, 259-65, 2009.

Takiguchi M, Oka S. Impact of human leukocyte
antigen-B*51-restricted cytotoxic T-lymphocytepressure on mutation patterns of nonnucleoside10) McCord, RA., Michishita, E., Hong, T., Berber, E.,
Boxer, LD., Kusumoto, R., Guan, S., Shi, X., Gozani,

reverse transcriptase inhibitor resistance. AIDS.

O., Burlingame, AL., Bohr, VA. and Chua, KF. SIRT624(5):F15-22, 2010.

stabilizes4) Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H,confers

resistance

toYamamoto M, Miyashita K, Ogawa S, Motomura K, MoriH, Nakamura H, Wakita T, Takeda N, Sato H.

Antimicrob Agents Chemother. 54:1596-602, 2010.

Structural5) Yokoyama M, Mori H, Sato H. Allosteric regulation
HIV-1

reversetranscriptase

byATP

biologicalconstraints

oncleavage sites in calicivirus precursor proteins.

nucleotide selection.. PLoS One. 5:e8867, 2010.

Virology. 394:119-29. 2009.

6) Nakajima N, Hata S, Sato Y, Tobiume M, Katano H,12) Sahbandar IN, Takahashi K, Djoerban Z, FirmansyahI, Naganawa S, Motomura K, Sato H, Kitamura K,H, Tashiro M, Kuroda M, Odai T, Urasawa N, Ogino

Pohan HT, Sato S. Current HIV type 1 molecularT, Hanaoka H, Watanabe M, Sata T. The first autopsy

epidemiology profile and identification of uniquecase of pandemic influenza (A/H1N1pdm) virus

recombinant forms in Jakarta, Indonesia.AIDS Res

infection in Japan: detection of a high copy number

Hum Retroviruses. 25:637-46,2009.

of the virus in type II alveolar epithelial cellsby pathological and virological examination. Jpnanddiversity of regions immediately upstream offor

Kaneko K, Nagata N, Kataoka M, Ainai A, Hasegawaat11) Oka T, Yokoyama M, Katayama K, Tsunemitsu H,efavirenz and nevirapine but not etravirine.

ofKinase

Aging (Albany NY), 1, 109-121, 2009.

mutations in human immunodeficiency virus type 1
transcriptase

Proteinchromatin for DNA double-strand break repair.

Oka S. Combination of V106I and V179D polymorphic

reverseDNA-dependent13) Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N,
Kubo Y. Raft localization of CXCR4 is primarily

J Infect Dis. 63:67-71, 2010.

required for X4-tropic human immunodeficiency virus

7) Okutani A, Sekizuka T, Boldbaatar B, Yamada A,

type 1 infection. Virology 386:23-31,2009.

Kuroda M, Inoue S. Phylogenetic typing of Bacillus

anthracis isolated in Japan by multiple locus
12